Introduction
Breast cancer resistance protein (BCRP/ABCG2) is known to be a half-transporter and is believed to act as a homodimer linked via disulfide bonds under physiological conditions (Allikmets et al., 1998; Doyle et al., 1998; Miyake et al., 1999; Kage et al., 2002) . Several studies have shown that BCRP is involved in the transport of antitumor agents, such as topotecan, methotrexate and doxorubicin, so that it contributes to multidrug resistance as P-glycoprotein (P-gp/ABCB1) and multidrug resistance-associated protein 1 (MRP1/ABCC1) (Doyle and Ross, 2003) .
In addition, it has been reported that BCRP recognizes other endogenous and exogenous compounds, for example, sulfated conjugates of steroid hormones and drugs (Suzuki et al., 2003) , dietary carcinogen PhIP (van Herwaarden et al., 2003) and chlorophyll-derived phototoxins (Jonker et al., 2002) . Together with the high expression of BCRP on the apical membrane of the intestine, liver and brain microvessel endothelium, it is now believed that BCRP has a physiological role as an efflux pump to protect the body against a variety of toxic agents (Jonker et al., 2002; Doyle and Ross, 2003; van Herwaarden et al., 2003) .
Hoechst 33342, a fluorescent dye useful to sort side population cells which are highly enriched for stem cell activity, is also a substrate of BCRP. Experiments carried out by several investigators have shown high expression of Bcrp1 compared with other ABC transporters in the population (Zhou et al., 2001 ) and a reduction in the number of This article has not been copyedited and formatted. The final version may differ from this version. 
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5 side population cells in Bcrp1-deficient mice (Zhou et al., 2002) , identifying BCRP expression as a molecular determinant of the Hoechst 33342 efflux phenotype.
Furthermore, a recent report by Mogi et al. (Mogi et al., 2003) indicated that Akt, which functions downstream from phosphatidylinositol 3-kinase (PI3K) as an important mediator of insulin or growth factors, modulates the Hoechst 33342 efflux ability by regulating the expression of Bcrp1.
Under pathophysiological conditions, regulation of transporters has been observed; not only transcriptional regulation of genes, but also differences in the subcellular distribution of proteins. For instance, canalicular ABC transporters such as bile salt export pump (BSEP/ABCB11) and MRP2 (ABCC2) are internalized into subapical domains under cholestatic conditions to protect epithelial cells in the bile duct from the toxic effects of their substrates (Trauner et al., 1997; Paulusma et al., 2000; Stieger et al., 2000) . The detailed mechanisms behind these observations remain unclear, although a proper regulation mechanism is crucial for the proper distribution of their substrates.
Understanding the mechanism could lead to the development of new treatment strategies.
In the present study, to investigate the effect of Akt activity on the cell surface 8 MD) with addition of 10% of fetal bovine serum, penicillin (100 units/ml), streptomycin (100 µg/ml), and G418 sulfate (400 µg/ml) at 37°C in an atmosphere containing 5% CO 2 and 95% humidity. µl streptavidin-agarose beads (Pierce) was added to the lysate, followed by incubation at 4°C overnight with end-over-end rotation. Following centrifugation, the beads were washed three times with lysis buffer, twice with high salt lysis buffer (50 mM Tris, 500 mM NaCl, 5 mM EDTA, 0.1% Triton-X 100, pH7.5), and once with low salt lysis buffer (50 mM Tris, pH7.5). The biotinylated proteins were released by incubation with 50 µl 3 x SDS loading buffer (BioLabs, Hertfordshire, UK) diluted to 1 x SDS with PBS for 5 min at 60°C. Samples of total cell lysates (15 µl) and biotinylated proteins (20 µl)
were subjected to Western blot analysis.
Western blot analysis. The total cell lysates diluted with 3 x SDS loading buffer
This article has not been copyedited and formatted. The final version may differ from this version. human BCRP showed apical localization as reported previously (Imai et al., 2003) .
After treatment with PI3K inhibitors, LY294002 or wortmannin, the cellular localization of human BCRP was altered; some of the protein molecules showed the intracellular localization, although the localization on the apical membrane was also significant (Figure 1 ). These observations were also confirmed by Western blot analysis. After treatment with LY294002 or wortmannin, the expression level of Akt itself seemed unchanged, whereas hardly any phospho-Akt was observed ( Figure 2A ). The band density of BCRP in the Western blot analysis of the total cell lysate was almost the same under all conditions. However, the cell surface BCRP, which was detected by the band in the Western blot analysis for biotinylated protein, was reduced after treatment with PI3K inhibitors ( Figure 2B ). Collectively, as phospho-Akt disappeared, internalization of BCRP from the cell surface was observed.
EGF treatment increases the cell surface expression of BCRP.
Characterization of the expression of BCRP was also performed after treatment with EGF. A stimulatory effect of EGF on the phosphorylation state of Akt was observed;
This article has not been copyedited and formatted. The final version may differ from this version. 12 the detected band for phospho-Akt appeared stronger after EGF treatment and there seemed to be no difference in the antibody against Akt ( Figure 3A) . Under
Akt-stimulated conditions, the relative ratio of the cell surface expression of BCRP increased compared with the control level ( Figure 3B ); more BCRP molecules on the cell surface was detected after stimulation by EGF whereas the apparent expression level of BCRP in the total cell lysate appeared to be unchanged. 
Immunolocalization of BCRP in
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13 BCRP appeared not only on the apical surface, but also in the intracellular compartment as was observed after the treatment with PI3K inhibitors (Figure 1 ).
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Discussion
In the present study, we observed the difference in the subcellular localization of human BCRP after treatments which cause alterations in the phosphorylation state of Akt by stimulating or inhibiting the upstream regulator, PI3K; treatment with PI3K inhibitors, LY294002 or wortmannin, induced internalization of BCRP (Figure 1 and 2) , and in addition, after incubation with EGF, the relative expression of BCRP on the cell surface increased (Figure 3 ). Furthermore, after transfection of the dominant-negative Akt cDNA into BCRP-expressing cells, the expression of BCRP seemed to spread to the intracellular domain in addition to the apical localization. Taken together, these observations indicate that the cell surface expression of human BCRP in polarized cells is modulated by the phosphorylation state of Akt.
It is possible that drug-drug interactions could be caused by this regulatory mechanism; if drugs influence the Akt activity, the in vivo transport activity of BCRP may also be modified due to the altered level of cell surface BCRP. Although many compounds are believed to inhibit the function of BCRP, all of them are not reported to inhibit directly the transport function of BCRP; for many of them, a shift in the cytotoxic effect of BCRP substrates (such as topotecan) in BCRP-expressing cells has been shown (Doyle and Ross, 2003) . Our hypothesis may be likely to hold true, particularly for EGF receptor inhibitors like CI1033 or Iressa, since they can inhibit the PI3K-Akt signaling pathway (Erlichman et al., 2001; Doyle and Ross, 2003) .
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Under physiological conditions, in most cases, the subcellular expression of BCRP has been believed to be on the plasma membrane (Rocchi et al., 2000) . However, a recent report by Summer et al. showed that the Bcrp1 protein in primary bronchial smooth muscle cell cultures and lavaged distal airway cells was confined to the intracellular compartment. Taking this information and our observations into account, BCRP/Bcrp1 localization may be correlated with endogenous Akt activity, although there is no direct evidence to confirm this yet. When Akt activity is modified by factors, such as dietary components or under pathophysiological conditions, the cellular localization of BCRP may also be modified, and consequently, the disposition of the substrate drugs may be altered. For example, green or black tea polyphenols are known to have the ability to down-regulate Akt activity; it is possible that the expression of BCRP in epithelial cells, particularly in small intestinal epithelial cells, could be affected by these compounds, due to high direct exposure (Klein and Fischer, 2002; Pianetti et al., 2002) .
Bcrp1-deficient mice are reported to exhibit no biochemical abnormalities under standard housing conditions (Jonker et al., 2002; Zhou et al., 2002) . However, they
show diet-dependent phototoxicity caused by insufficient protection against chlorophyll-derived dietary phototoxins which are Bcrp1 substrates (Jonker et al., 2002) .
Our results indicate that the lower activity of Akt causes lower expression of BCRP on the cell surface and, therefore, it is possible that in mice lacking Akt(s) a similar This article has not been copyedited and formatted. The final version may differ from this version. 16 phenotype may be observed. Although there are some reports on the mice being knocked out of genes encoding Akt1 (Chen et al., 2001; Cho et al., 2001b) or Akt2 (Cho et al., 2001a; Garofalo et al., 2003) or both of Akt1 and Akt2 (Peng et al., 2003) , the sensitivity to dietary chlorophyll-breakdown products has not been reported. Analysis of the photosensitive behavior of these mice is an attractive topic for further study.
Besides BCRP, there are a few membrane proteins whose cell surface expression is regulated by Akt: a facilitative glucose transporter 4 (GLUT4) (Foster et al., 2001) and under the immunohistochemical staining conditions used in this study.
Since there is no putative consensus site for phosphorylation by Akt (Brazil and Hemmings, 2001 ), a direct interaction between BCRP and Akt is unexpected. For consideration of the detailed mechanism involved, information on GLUT4 regulation may be useful. In a recent report, TUG was identified as a putative tether, containing a UBX domain, for the regulation of intracellular sorting of GLUT4 (Bogan et al., 2003) .
In non-stimulated cells, TUG and GLUT4 form the complex via direct binding, and this 
